NCT06243341

Brief Summary

In this randomized crossover study, ten elite healthy male basketball players were included. Following a 17:00 PM training routine, participants completed a two-week supplementation with 2000 mg of MACA or placebo. After supplementation, participants underwent a Basketball Jump Shooting Accuracy Test and Repeated Sprint Ability Test.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
10

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jun 2022

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2022

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 30, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2022

Completed
1.3 years until next milestone

First Submitted

Initial submission to the registry

January 14, 2024

Completed
23 days until next milestone

First Posted

Study publicly available on registry

February 6, 2024

Completed
Last Updated

February 6, 2024

Status Verified

February 1, 2024

Enrollment Period

4 months

First QC Date

January 14, 2024

Last Update Submit

February 1, 2024

Conditions

Keywords

Lepidium meyeniiBasketball Jump Shooting Accuracy TestRepeated Sprint Ability Testblood lactate clearance rateergogenic aids

Outcome Measures

Primary Outcomes (1)

  • Countermovement jump test

    Three jumps were measured with 1 minute rest for each participant.

    immediately after 2 weeks intervention

Secondary Outcomes (2)

  • Basketball Jump Shooting Accuracy Test

    immediately after 2 weeks intervention

  • Repeated Sprint Ability Test

    immediately after 2 weeks intervention

Study Arms (2)

MACA (MC)

EXPERIMENTAL

Daily MACA supplementation for two weeks.

Dietary Supplement: Lepidium meyenii (MACA)

placebo

PLACEBO COMPARATOR

Daily placebo supplementation for two weeks.

Dietary Supplement: Lepidium meyenii (MACA)

Interventions

Lepidium meyenii (MACA)DIETARY_SUPPLEMENT

The MACA supplement is derived from a concentrated 6:1 blend of black, red, and yellow MACA root compounds, with an 80:15:5 ratio respectively.

Also known as: 100% corn-starch maltodextrin powder
MACA (MC)placebo

Eligibility Criteria

Age20 Years - 30 Years
Sexmale(Gender-based eligibility)
Gender Eligibility DetailsOnly adult male participants were recruited
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • (i) healthy male adults, those individuals who are free of pain, insomnia, or other injuries recently, without any medication used in recent 2 months,
  • (ii) basketball players competing in a Taiwan university basketball association for more than two years.

You may not qualify if:

  • (i) were below 20 years old,
  • (ii) did not have won at least eighth place in national-level basketball competitions,
  • (iii) were with cardiovascular diseases or any disease that made subjects feel ill.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

National Taiwan University of Sport

Taichung, 404, Taiwan

Location

Related Publications (2)

  • Stone M, Ibarra A, Roller M, Zangara A, Stevenson E. A pilot investigation into the effect of maca supplementation on physical activity and sexual desire in sportsmen. J Ethnopharmacol. 2009 Dec 10;126(3):574-6. doi: 10.1016/j.jep.2009.09.012. Epub 2009 Sep 23.

  • Wu PS, Wu SH, Jiang RS, Chen CH, Chen BW, Chiu CH. The Impact of Lepidium meyenii (MACA) Supplementation on Basketball-related Performance and Antifatigue Ability: A Double-blind Crossover Study. J Physiol Investig. 2025 Sep 1;68(5):297-304. doi: 10.4103/ejpi.EJPI-D-25-00037. Epub 2025 Sep 17.

Study Officials

  • Che-Hsiu Chen, PhD

    Sport Science Research Center

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Masking Details
a double blind crossover study
Purpose
BASIC SCIENCE
Intervention Model
CROSSOVER
Model Details: a double blind crossover study
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

January 14, 2024

First Posted

February 6, 2024

Study Start

June 1, 2022

Primary Completion

September 30, 2022

Study Completion

September 30, 2022

Last Updated

February 6, 2024

Record last verified: 2024-02

Data Sharing

IPD Sharing
Will not share

No personal data of participants will be provided

Locations